Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn save search
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight LossExpects to Commence Phase 2a of CAReS During the First Quarter of 2023
Published: 2023-02-02 (Crawled : 15:20) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -2.3%
H: 2.11%
C: 1.78%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.31%
H: 0.05%
C: -0.33%
ARTL | $1.28 -1.94% 5.5K
|
Health Technology
|
| O: -1.27%
H: 1.67%
C: -0.96%
art27 treatment cares trial art27.13 phase 2b
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -2.3%
H: 2.11%
C: 1.78%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.31%
H: 0.05%
C: -0.33%
tezspire approved
Artelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published: 2023-02-02 (Crawled : 14:20) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -2.3%
H: 2.11%
C: 1.78%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.31%
H: 0.05%
C: -0.33%
ARTL | $1.28 -1.94% 5.5K
|
Health Technology
|
| O: -1.27%
H: 1.67%
C: -0.96%
art27 treatment cares trial art27.13 phase 2b
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published: 2023-01-31 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.22%
H: 0.52%
C: 0.51%
growth
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published: 2023-01-30 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.09%
H: 2.18%
C: -1.43%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.19%
H: 0.13%
C: -0.69%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.0%
H: 0.79%
C: -0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.36%
C: -3.53%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.13%
H: 0.78%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.3%
H: 0.06%
C: -0.81%
global report gastrointestinal therapeutics market
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer
Published: 2023-01-30 (Crawled : 14:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.3%
H: 0.06%
C: -0.81%
lung trial cancer initiated
GERD market size to increase by USD 908.49 million; North America to account for 38% of market growth - Technavio
Published: 2023-01-25 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.2%
H: 0.64%
C: -1.44%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.69%
H: 0.92%
C: 0.66%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -2.25%
H: 2.04%
C: 0.91%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.66%
H: 1.62%
C: 1.2%
america growth market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Published: 2023-01-23 (Crawled : 13:00) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.18%
H: 0.85%
C: -2.21%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.64%
H: 0.57%
C: -1.6%
acquire
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -1.68%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.5%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.16%
H: 1.62%
C: -0.54%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.17%
H: 0.25%
C: -2.96%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.56%
H: 0.97%
C: -1.87%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.57%
H: 0.84%
C: -0.01%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.93%
H: 0.01%
C: -1.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: -1.1%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.17%
C: -1.01%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.4%
H: 0.75%
C: -1.21%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: -1.5%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.34%
H: 0.46%
C: -2.45%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -1.87%
therapy growth
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
Published: 2023-01-18 (Crawled : 15:00) - globenewswire.com
HCM | $16.49 0.8% 0.79% 61K
|
Health Technology
|
| O: 1.32%
H: 4.49%
C: 1.01%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
orpathys drug agreement china
Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES
Published: 2023-01-17 (Crawled : 17:00) - globenewswire.com
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.76%
H: 0.03%
C: -1.23%
group
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published: 2023-01-13 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.13%
H: 0.76%
C: 0.76%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.77%
H: 0.63%
C: 0.63%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.13%
H: 2.35%
C: 2.16%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.44%
H: 1.39%
C: 0.74%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.15%
H: 0.65%
C: 0.4%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.47%
H: 0.47%
C: 0.14%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.13%
H: 1.04%
C: 0.57%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
BMRN | $88.68 -1.54% -1.57% 1.8M
|
Health Technology
|
| O: -1.16%
H: 2.27%
C: 0.42%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.27%
H: 0.78%
C: 0.15%
treatment disease expected
Global Head And Neck Cancer Therapeutics Market Report 2022: Sector to Reach $2.5 Billion by 2028 at a 12.3% CAGR
Published: 2023-01-12 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.13%
H: 0.76%
C: 0.76%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.77%
H: 0.63%
C: 0.63%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.13%
H: 2.35%
C: 2.16%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.13%
H: 1.04%
C: 0.57%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.27%
H: 0.78%
C: 0.15%
global report therapeutics cancer market
Global Nasal Vaccines Markets and Pipeline Analysis Research Report 2022: A Major Game Changer in Blocking the Transmission of Diseases Such as COVID-19
Published: 2023-01-10 (Crawled : 21:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.28%
H: 0.0%
C: -0.82%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.33%
H: 0.13%
C: -1.28%
covid-19 research global report
Immune Checkpoint Inhibitors Market Predicted to Reach USD 155.1 Billion, Globally, by 2031 at 16.1% CAGR: Allied Market Research
Published: 2023-01-09 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.81%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -1.23%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.35%
H: 0.86%
C: -0.21%
research market
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
Published: 2023-01-05 (Crawled : 16:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.49%
H: 1.65%
C: 0.94%
lung biomarker cancer study
Genomic Vision announces successful beta testing of FiberSmart®
Published: 2023-01-05 (Crawled : 07:00) - globenewswire.com
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.49%
H: 1.65%
C: 0.94%
fibersmart genomic
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published: 2023-01-04 (Crawled : 23:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.93%
H: 3.08%
C: 3.08%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.89%
H: 1.18%
C: 0.52%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.85%
H: 0.2%
C: -0.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.62%
H: 0.54%
C: -0.12%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.49%
H: 1.65%
C: 0.94%
treatment patent global report growing diabetes growth market
Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -0.74%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.01%
H: 0.08%
C: -0.95%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.37%
H: 0.89%
C: 0.4%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.46%
H: 0.38%
C: 0.01%
global report sanofi market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -0.74%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.08%
H: 0.0%
C: -0.25%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.08%
H: 0.21%
C: -0.1%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.01%
H: 0.08%
C: -0.95%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.16%
C: -0.47%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.04%
H: 0.21%
C: -0.25%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.08%
H: 0.66%
C: 0.61%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -0.32%
H: 2.91%
C: 2.75%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.46%
H: 0.38%
C: 0.01%
global disease report therapeutics cancer market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.